Form 4: NEXGEL CEO Adam R. Levy Sells 4,000 Shares for Tax Planning

NEXGEL's CEO, Adam R. Levy, sold 4,000 shares of common stock on April 1, 2025, at an average price of $3.0096 per share, according to a Form 4 filing.

Summary

• Adam R. Levy, the CEO of NEXGEL, INC., reported the sale of 4,000 shares of common stock on April 1, 2025.
• The shares were sold at a weighted average price of $3.0096, with individual transactions ranging from $3.0000 to $3.0100 per share.
• The sale was executed under a pre-arranged Rule 10b5-1 trading plan for tax planning purposes.
• Following the transaction, Levy directly owns 370,284 shares of NEXGEL common stock.

Sentiment

Score: 5

Explanation: Neutral sentiment as it's a routine disclosure of a planned stock sale by an executive for tax purposes. It doesn't inherently indicate positive or negative news about the company's performance.

Industry Context

This filing is a routine disclosure of insider trading activity. It's common for executives to sell shares for personal financial planning, including tax purposes. The use of a 10b5-1 plan suggests the sales were pre-planned and not based on inside information.

Stakeholder Impact

• The sale could have a minor impact on shareholders if it creates downward pressure on the stock price, although the amount of shares sold is unlikely to have a significant impact.

Key Dates

Keywords

NEXGEL, Adam R. Levy, Form 4, Stock Sale, Rule 10b5-1, Insider Trading, Executive Compensation, Share Transaction